Nawab Qizilbash

Senior Clinical Epidemiologist & Director Of OXON at OXON Epidemiology

Nawab Qizilbash, MD DPhil(Oxon.) has been involved in various academic and industry epidemiology projects. Currently, Nawab holds the position of Honorary Associate Professor in Epidemiology and Honorary Senior Lecturer in Epidemiology at the London School of Hygiene & Tropical Medicine. Additionally, Nawab is the Senior Clinical Epidemiologist and Head of OXON EPIDEMIOLOGY at OXON Epidemiology. Nawab is also an Honorary Consultant Geriatrician at Hospital Cantoblanco in Madrid and a Member of Green Templeton College at Oxford University. Furthermore, Nawab has a strong publication record and has served in various other medical and research roles throughout their career.

Location

London, United Kingdom

Links


Org chart


Teams

This person is not in any teams


Offices


OXON Epidemiology

OXON Epidemiology is a European full-service Contract Research Organization (CRO) specialising in the generation of Real-World Evidence (RWE) via primary data collection, secondary data and hybrid observational studies, pragmatic trials, synthesis research, and data analysis and modelling of drugs and devices in all major therapeutic areas. OXON strives to be the Go-To leader in the design and implementation of outstanding observational studies. Our mission is to integrate methodological and statistical thinking and insights to maximize value and provide solutions for our clients. As a leader CRO, OXON provides a unique blend of quality science and operational experience to support pharmaceutical and medical devices companies worldwide to obtain high-quality RWE for Safety, Market Access, and Clinical Development for improving patients’ and public health: • Multi-country field, chart review and database epidemiological studies • Patient registries • Pragmatic Trials • Systematic Reviews & Meta-analysis • PASS and PAES studies • Risk minimisation studies • Risk management • Statistical signal detection & analysis • Quantitative benefit-risk analysis for CTD / PBRER • Patient reported outcomes • Health economics & modelling • Meta-analysis and Evidence strategy


Employees

11-50

Links